JW190426 FY19 new start
Ended Definitive Contract Awarded Last action
- Contract number
- W81XWH20C0116
- Awardee
-
Seattle Institute For Biomedical And Clinical Research UEI DRRKVZVXSND3
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $4,452,838
Award facts
- Opportunity
-
- W81XWH19RJWMR Solicitation number
- Contract value 100% obligated
- $4,452,838.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Fixed Price Level of Effort
- Place of performance
- Seattle, WA 98108, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $4,452,838 |
About this award
The Defense Health Agency awarded a $4.45 million definitive contract to the Seattle Institute for Biomedical and Clinical Research on September 25, 2020, for the development of F-18 labeled radiotracers for positron emission tomography (PET) imaging of brain alpha-1A adrenoceptors. This fixed-price level-of-effort contract, which commenced as a fiscal year 2019 new start and extends through September 2026, supports Defense Health Agency research initiatives focused on advancing medical imaging technologies. The work is being performed in Seattle, Washington, and the contract was awarded without set-aside designation.
The prime contractor, Seattle Institute for Biomedical and Clinical Research, is a non-profit research entity affiliated with the Department of Veterans Affairs that specializes in neurodegenerative diseases and neurological research. The project involves multiple subcontractors providing specialized support, including the University of Washington's Office of Sponsored Programs, which leads radioligand development and in vivo imaging studies, including vertebrate animal and human imaging; Inotiv, Inc., which performs toxicology studies; and the Portland VA Research Foundation, which provides receptor binding affinity determinations and pharmacological screening services. This collaborative structure enables the prime contractor to integrate radiochemistry expertise, preclinical safety evaluation, and specialized assay services necessary for advancing radioligand development toward Investigational New Drug application support for post-traumatic stress disorder therapeutic research.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| University Of Washington | $65,550 | |
| University Of Washington | $290,228 |
Quick answers
Who was awarded contract W81XWH20C0116?
W81XWH20C0116 was awarded to Seattle Institute For Biomedical And Clinical Research by Defense Health Agency (Department of Defense) on September 25, 2020.
How much is contract W81XWH20C0116 worth?
The government has obligated $4,452,838 on W81XWH20C0116.
Was contract W81XWH20C0116 competed?
The extent of competition for W81XWH20C0116 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award